Produktname:7-(2-methyl-4-nitrophenoxy)-[1,2,4]triazolo[1,5-a]pyridine
IUPAC Name:7-(2-methyl-4-nitrophenoxy)-[1,2,4]triazolo[1,5-a]pyridine
- CAS:937263-44-0
- Molekulare Formel:C13H10N4O3
- Reinheit:95%+
- Katalognummer:CM1019389
- Molekulargewicht:270.25
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:937263-44-0
- Molekulare Formel:C13H10N4O3
- Schmelzpunkt:-
- SMILES-Code:CC1=C(C=CC(=C1)[N+](=O)[O-])OC2=CC3=NC=NN3C=C2
- Dichte:
- Katalognummer:CM1019389
- Molekulargewicht:270.25
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Column Infos
- Tucatinib
- In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.